Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc > Interesting at least

<< Previous

Bullboard Posts

Next >>

Comment by MrMugsyon Aug 02, 2022 2:47pm

179 Views

Post# 34866376

RE:RE:Interesting at least

EbbFlow88 wrote: Kind of odd to get over the 10% threshold and then sell 100,000 shares for roughly 50 cent gain.

Think it's more interesting to see how the market runs for cover - scared silly by it.

Would be interesting to see if they made a few smaller winning sells in order to move cash to some depressed opportunity ... OR ... if it was only a GUD sale. Surely there's method to the madness.

Regardless, guessing it doesn't really mean anything for our pharma roll-out.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario